Literature DB >> 26871637

Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing.

Xinping Yang1, Jasmin Coulombe-Huntington2, Shuli Kang3, Gloria M Sheynkman4, Tong Hao4, Aaron Richardson4, Song Sun5, Fan Yang6, Yun A Shen4, Ryan R Murray7, Kerstin Spirohn4, Bridget E Begg4, Miquel Duran-Frigola8, Andrew MacWilliams7, Samuel J Pevzner9, Quan Zhong7, Shelly A Trigg7, Stanley Tam7, Lila Ghamsari7, Nidhi Sahni4, Song Yi4, Maria D Rodriguez7, Dawit Balcha4, Guihong Tan10, Michael Costanzo10, Brenda Andrews11, Charles Boone11, Xianghong J Zhou12, Kourosh Salehi-Ashtiani7, Benoit Charloteaux4, Alyce A Chen4, Michael A Calderwood4, Patrick Aloy13, Frederick P Roth14, David E Hill4, Lilia M Iakoucheva15, Yu Xia16, Marc Vidal17.   

Abstract

While alternative splicing is known to diversify the functional characteristics of some genes, the extent to which protein isoforms globally contribute to functional complexity on a proteomic scale remains unknown. To address this systematically, we cloned full-length open reading frames of alternatively spliced transcripts for a large number of human genes and used protein-protein interaction profiling to functionally compare hundreds of protein isoform pairs. The majority of isoform pairs share less than 50% of their interactions. In the global context of interactome network maps, alternative isoforms tend to behave like distinct proteins rather than minor variants of each other. Interaction partners specific to alternative isoforms tend to be expressed in a highly tissue-specific manner and belong to distinct functional modules. Our strategy, applicable to other functional characteristics, reveals a widespread expansion of protein interaction capabilities through alternative splicing and suggests that many alternative "isoforms" are functionally divergent (i.e., "functional alloforms").
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26871637      PMCID: PMC4882190          DOI: 10.1016/j.cell.2016.01.029

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  43 in total

1.  GATEWAY recombinational cloning: application to the cloning of large numbers of open reading frames or ORFeomes.

Authors:  A J Walhout; G F Temple; M A Brasch; J L Hartley; M A Lorson; S van den Heuvel; M Vidal
Journal:  Methods Enzymol       Date:  2000       Impact factor: 1.600

2.  Partial COL1A2 gene duplication produces features of osteogenesis imperfecta and Ehlers-Danlos syndrome type VII.

Authors:  M L Raff; W J Craigen; L T Smith; D R Keene; P H Byers
Journal:  Hum Genet       Date:  2000-01       Impact factor: 4.132

3.  Towards a proteome-scale map of the human protein-protein interaction network.

Authors:  Jean-François Rual; Kavitha Venkatesan; Tong Hao; Tomoko Hirozane-Kishikawa; Amélie Dricot; Ning Li; Gabriel F Berriz; Francis D Gibbons; Matija Dreze; Nono Ayivi-Guedehoussou; Niels Klitgord; Christophe Simon; Mike Boxem; Stuart Milstein; Jennifer Rosenberg; Debra S Goldberg; Lan V Zhang; Sharyl L Wong; Giovanni Franklin; Siming Li; Joanna S Albala; Janghoo Lim; Carlene Fraughton; Estelle Llamosas; Sebiha Cevik; Camille Bex; Philippe Lamesch; Robert S Sikorski; Jean Vandenhaute; Huda Y Zoghbi; Alex Smolyar; Stephanie Bosak; Reynaldo Sequerra; Lynn Doucette-Stamm; Michael E Cusick; David E Hill; Frederick P Roth; Marc Vidal
Journal:  Nature       Date:  2005-09-28       Impact factor: 49.962

4.  Mutation analysis of COL1A1 and COL1A2 in patients diagnosed with osteogenesis imperfecta type I-IV.

Authors:  Rebecca Pollitt; Robert McMahon; Janice Nunn; Robert Bamford; Amal Afifi; Nicholas Bishop; Ann Dalton
Journal:  Hum Mutat       Date:  2006-07       Impact factor: 4.878

Review 5.  Alternative splicing: new insights from global analyses.

Authors:  Benjamin J Blencowe
Journal:  Cell       Date:  2006-07-14       Impact factor: 41.582

6.  Domain assignment for protein structures using a consensus approach: characterization and analysis.

Authors:  S Jones; M Stewart; A Michie; M B Swindells; C Orengo; J M Thornton
Journal:  Protein Sci       Date:  1998-02       Impact factor: 6.725

7.  Alternative splicing in concert with protein intrinsic disorder enables increased functional diversity in multicellular organisms.

Authors:  Pedro R Romero; Saima Zaidi; Ya Yin Fang; Vladimir N Uversky; Predrag Radivojac; Christopher J Oldfield; Marc S Cortese; Megan Sickmeier; Tanguy LeGall; Zoran Obradovic; A Keith Dunker
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-22       Impact factor: 11.205

Review 8.  Regulation of apoptosis by alternative pre-mRNA splicing.

Authors:  Christian Schwerk; Klaus Schulze-Osthoff
Journal:  Mol Cell       Date:  2005-07-01       Impact factor: 17.970

9.  DILIMOT: discovery of linear motifs in proteins.

Authors:  Victor Neduva; Robert B Russell
Journal:  Nucleic Acids Res       Date:  2006-07-01       Impact factor: 16.971

10.  hORFeome v3.1: a resource of human open reading frames representing over 10,000 human genes.

Authors:  Philippe Lamesch; Ning Li; Stuart Milstein; Changyu Fan; Tong Hao; Gabor Szabo; Zhenjun Hu; Kavitha Venkatesan; Graeme Bethel; Paul Martin; Jane Rogers; Stephanie Lawlor; Stuart McLaren; Amélie Dricot; Heather Borick; Michael E Cusick; Jean Vandenhaute; Ian Dunham; David E Hill; Marc Vidal
Journal:  Genomics       Date:  2007-01-05       Impact factor: 5.736

View more
  193 in total

Review 1.  Intersections of post-transcriptional gene regulatory mechanisms with intermediary metabolism.

Authors:  Waqar Arif; Gandhar Datar; Auinash Kalsotra
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2017-01-11       Impact factor: 4.490

Review 2.  Alternative splicing and the evolution of phenotypic novelty.

Authors:  Stephen J Bush; Lu Chen; Jaime M Tovar-Corona; Araxi O Urrutia
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-02-05       Impact factor: 6.237

3.  Activation-Dependent TRAF3 Exon 8 Alternative Splicing Is Controlled by CELF2 and hnRNP C Binding to an Upstream Intronic Element.

Authors:  Astrid-Solveig Schultz; Marco Preussner; Mario Bunse; Rotem Karni; Florian Heyd
Journal:  Mol Cell Biol       Date:  2017-03-17       Impact factor: 4.272

4.  Exploring the functional impact of alternative splicing on human protein isoforms using available annotation sources.

Authors:  Dinanath Sulakhe; Mark D'Souza; Sheng Wang; Sandhya Balasubramanian; Prashanth Athri; Bingqing Xie; Stefan Canzar; Gady Agam; T Conrad Gilliam; Natalia Maltsev
Journal:  Brief Bioinform       Date:  2019-09-27       Impact factor: 11.622

5.  Accurate Estimation of Context-Dependent False Discovery Rates in Top-Down Proteomics.

Authors:  Richard D LeDuc; Ryan T Fellers; Bryan P Early; Joseph B Greer; Daniel P Shams; Paul M Thomas; Neil L Kelleher
Journal:  Mol Cell Proteomics       Date:  2019-01-15       Impact factor: 5.911

6.  Characterization of cis-acting elements that control oscillating alternative splicing.

Authors:  Gesine Goldammer; Alexander Neumann; Miriam Strauch; Michaela Müller-McNicoll; Florian Heyd; Marco Preußner
Journal:  RNA Biol       Date:  2018-09-10       Impact factor: 4.652

7.  Neuroblastoma RAS viral oncogene homolog mRNA is differentially spliced to give five distinct isoforms: implications for melanoma therapy.

Authors:  Megan C Duggan; Kelly Regan-Fendt; Gonzalo N Olaverria Salavaggione; John Harrison Howard; Andrew R Stiff; Julia Sabella; Nicholas Latchana; Joseph Markowitz; Alejandro Gru; Susheela Tridandapani; Ann-Kathrin Eisfeld; Albert de la Chapelle; William E Carson
Journal:  Melanoma Res       Date:  2019-10       Impact factor: 3.599

8.  ProForma: A Standard Proteoform Notation.

Authors:  Richard D LeDuc; Veit Schwämmle; Michael R Shortreed; Anthony J Cesnik; Stefan K Solntsev; Jared B Shaw; Maria J Martin; Juan A Vizcaino; Emanuele Alpi; Paul Danis; Neil L Kelleher; Lloyd M Smith; Ying Ge; Jeffrey N Agar; Julia Chamot-Rooke; Joseph A Loo; Ljiljana Pasa-Tolic; Yury O Tsybin
Journal:  J Proteome Res       Date:  2018-02-14       Impact factor: 4.466

Review 9.  Evolution of Structural Biology through the Lens of Mass Spectrometry.

Authors:  Upneet Kaur; Danté T Johnson; Emily E Chea; Daniel J Deredge; Jessica A Espino; Lisa M Jones
Journal:  Anal Chem       Date:  2018-12-06       Impact factor: 6.986

10.  e-MutPath: computational modeling reveals the functional landscape of genetic mutations rewiring interactome networks.

Authors:  Yongsheng Li; Brandon Burgman; Ishaani S Khatri; Sairahul R Pentaparthi; Zhe Su; Daniel J McGrail; Yang Li; Erxi Wu; S Gail Eckhardt; Nidhi Sahni; S Stephen Yi
Journal:  Nucleic Acids Res       Date:  2021-01-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.